about
Crystal structure of the Ig1 domain of the neural cell adhesion molecule NCAM2 displays domain swappingStructural model and trans-interaction of the entire ectodomain of the olfactory cell adhesion moleculeZippers make signals: NCAM-mediated molecular interactions and signal transductionAnti-inflammatory properties of a novel peptide interleukin 1 receptor antagonistCell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylationIndividual cell motility studied by time-lapse video recording: influence of experimental conditions.Automated in vitro screening of teratogens.Discriminative power of an assay for automated in vitro screening of teratogens.Identification of NCAM-binding peptides promoting neurite outgrowth via a heterotrimeric G-protein-coupled pathway.Evaluation of cell morphology.Human ASPL/TUG interacts with p97 and complements the proteasome mislocalization of a yeast ubx4 mutant, but not the ER-associated degradation defect.Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects.The neural cell adhesion molecule NCAM2/OCAM/RNCAM, a close relative to NCAM.IGSF9 family proteins.Neural cell adhesion molecules belonging to the family of leucine-rich repeat proteins.Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.Cell-cycle-dependent regulation of cell motility and determination of the role of Rac1.A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35.Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM.Effect of cytochalasins on F-actin and morphology of Ehrlich ascites tumor cells.NCAM2 Fibronectin type-III domains form a rigid structure that binds and activates the Fibroblast Growth Factor Receptor.NCAM regulates cell motility.Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeletonCharacterization of BASP1-mediated neurite outgrowthIntroduction. Cell adhesion molecules: implications in neurological diseases
P50
Q27651640-CF010941-A356-493B-A537-CA9BB16E9997Q27666681-04A8C648-1FDE-47D0-98D4-70F007BE8595Q28609109-B3C857BD-F9B5-4440-8AA9-38FE8788AEC8Q28659160-08C81652-5C37-4207-8921-C58041918A79Q30495932-3F699A94-7558-4EBA-BBAE-7551FA2081D9Q30890954-EE0EAA01-FD1E-426E-B4C5-C8EDDDB0BD96Q31062094-B48FA435-BE3B-45DF-93C4-F2569F5D1B9DQ33202681-E55705C0-5E1A-4A54-957B-EAE64C40CF2DQ33298836-B3DA6D06-C330-4DF3-882B-65794B6FA6E5Q34145965-7D4E1997-AD7C-4733-849F-665E6BF48F0DQ35216145-01E93067-225D-4A47-9A3F-7FFAA88F9A16Q37471491-98087F31-7235-4953-88F0-588E4A379BB7Q37657310-7AB2A30B-7A13-414C-9B9B-C4586EEEAD91Q38082408-8D54962E-8BBC-4CA9-806C-1649907F7102Q38258513-C8D82961-8E50-4AE1-995A-7A6D00F9612CQ38269703-07AA559D-1978-4A02-9DB0-19AB5CB3DFF6Q39570462-2186C3FB-B6D6-4888-9F70-D231BB3598D1Q40565449-FDA15BFD-2555-4734-9278-9FBA62E877D9Q48309863-60D00F4C-6813-416C-8145-BEEDFE5511B7Q48374878-0F058DD5-D481-4180-8735-D2BAD05FC974Q48425587-55F73DDA-A85C-4792-A569-DDB347ED59A6Q52541552-72749943-426F-4EB1-87B6-8B41D3CCABE7Q55422481-DC1EFF3D-6DE5-46DB-A270-88B8BF73B1A5Q55473712-F34B7B67-6BDA-4F52-B1F0-E3AC350F29F2Q74658942-6134D44A-5081-46CC-9776-C18EA9EAF530Q81158452-861A9783-B771-405D-B08C-77ACF6B1EDF2Q85732124-9BB3BA95-7164-46E5-8B12-7AE0000CF0DC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Schledermann Walmod
@ast
Peter Schledermann Walmod
@en
Peter Schledermann Walmod
@es
Peter Schledermann Walmod
@nl
Peter Schledermann Walmod
@sl
type
label
Peter Schledermann Walmod
@ast
Peter Schledermann Walmod
@en
Peter Schledermann Walmod
@es
Peter Schledermann Walmod
@nl
Peter Schledermann Walmod
@sl
prefLabel
Peter Schledermann Walmod
@ast
Peter Schledermann Walmod
@en
Peter Schledermann Walmod
@es
Peter Schledermann Walmod
@nl
Peter Schledermann Walmod
@sl
P214
P244
P1053
B-2130-2008
P106
P21
P214
P244
n2014184308
P31
P3829
P496
0000-0001-6350-2727
P734
P735
P7859
lccn-n2014184308